Cargando…

[(68)Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with (18)F[FDG] PET Imaging

People living with human immunodeficiency virus (PLHIV) have excess risk of atherosclerotic cardiovascular disease (ASCVD). Arterial inflammation is the hallmark of atherogenesis and its complications. In this study we aimed to perform a head-to-head comparison of fluorine-18 fluorodeoxyglucose posi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawal, Ismaheel O., Popoola, Gbenga O., Mahapane, Johncy, Kaufmann, Jens, Davis, Cindy, Ndlovu, Honest, Maserumule, Letjie C., Mokoala, Kgomotso M. G., Bouterfa, Hakim, Wester, Hans-Jürgen, Zeevaart, Jan Rijn, Sathekge, Mike M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7761707/ https://www.ncbi.nlm.nih.gov/pubmed/33287237 http://dx.doi.org/10.3390/biom10121629

Ejemplares similares

Correlation between [(68)Ga]Ga-FAPI-46 PET Imaging and HIF-1α Immunohistochemical Analysis in Cervical Cancer: Proof-of-Concept
por: Mokoala, Kgomotso M. G., et al.
Publicado: (2023)

A Prospective Investigation of Tumor Hypoxia Imaging with (68)Ga-Nitroimidazole PET/CT in Patients with Carcinoma of the Cervix Uteri and Comparison with (18)F-FDG PET/CT: Correlation with Immunohistochemistry
por: Mokoala, Kgomotso M. G., et al.
Publicado: (2022)

(68)Ga-PSMA-11 PET/CT Initial Staging in Black and White South African Males with ISUP Grade Group 1 and 2 Prostate Adenocarcinoma
por: Maserumule, Letjie C., et al.
Publicado: (2022)

Pattern of Prostate Cancer Recurrence Assessed by (68)Ga-PSMA-11 PET/CT in Men Treated with Primary Local Therapy
por: Lawal, Ismaheel O., et al.
Publicado: (2021)

Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [(68)Ga]pentixafor
por: Poschenrieder, Andreas, et al.
Publicado: (2016)

Accuracy of PET quantification in [(68)Ga]Ga-pentixafor PET/MR imaging of carotid plaques
por: Rausch, Ivo, et al.
Publicado: (2020)

FDG PET/CT for evaluating systemic arterial inflammation induced by anthracycline-based chemotherapy of Hodgkin lymphoma: A retrospective cohort study
por: Lawal, Ismaheel O., et al.
Publicado: (2020)

(68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma
por: Lapa, Constantin, et al.
Publicado: (2016)

[(68)Ga]-Pentixafor PET/CT for CXCR4-Mediated Imaging of Vestibular Schwannomas
por: Breun, Maria, et al.
Publicado: (2019)

(68)Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans
por: Sathekge, Mike, et al.
Publicado: (2017)

(68)Ga-PSMA-HBED-CC PET imaging in breast carcinoma patients
por: Sathekge, Mike, et al.
Publicado: (2016)

A dataset of [(68)Ga]Ga-Pentixafor PET/CT images of patients with high-grade Glioma
por: Roustaei, Hessamoddin, et al.
Publicado: (2023)

The Role of [(68)Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review
por: Albano, Domenico, et al.
Publicado: (2022)

(225)Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
por: Sathekge, Mike, et al.
Publicado: (2023)

[(68)Ga]Pentixafor PET/MR imaging of chemokine receptor 4 expression in the human carotid artery
por: Li, Xiang, et al.
Publicado: (2019)

CXCR4 PET imaging of mantle cell lymphoma using [(68)Ga]Pentixafor: comparison with [(18)F]FDG-PET
por: Mayerhoefer, Marius E., et al.
Publicado: (2021)

Imaging findings and clinical relevance of (68)Ga-Pentixafor PET in atherosclerosis: a systematic review
por: Wang, Min, et al.
Publicado: (2023)

mCRPC Patients Receiving (225)Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
por: Sathekge, Mike, et al.
Publicado: (2022)

Current Status of (68)Ga-Pentixafor in Solid Tumours
por: Hadebe, Bawinile, et al.
Publicado: (2022)

[68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques
por: Li, Xiang, et al.
Publicado: (2017)

CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather
por: Jacobs, Sarah M., et al.
Publicado: (2021)

Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [(68)Ga]Ga-PentixaFor PET/CT
por: Serfling, Sebastian E., et al.
Publicado: (2022)

[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer - initial experience
por: Lapa, Constantin, et al.
Publicado: (2016)

Reduced splenic uptake on (68)Ga-Pentixafor-PET/CT imaging in multiple myeloma - a potential imaging biomarker for disease prognosis
por: Kraus, Sabrina, et al.
Publicado: (2022)

Prospective non-invasive evaluation of CXCR4 expression for the diagnosis of MALT lymphoma using [(68)Ga]Ga-Pentixafor-PET/MRI
por: Haug, Alexander R., et al.
Publicado: (2019)

Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary Tuberculosis
por: Lawal, Ismaheel O., et al.
Publicado: (2022)

(68)Ga-FAPI-PET/CT in patients with various gynecological malignancies
por: Dendl, Katharina, et al.
Publicado: (2021)

Imaging Inflammation in Atherosclerosis with CXCR4-Directed [(68)Ga]PentixaFor PET/MRI—Compared with [(18)F]FDG PET/MRI
por: Lu, Xia, et al.
Publicado: (2022)

Automated synthesis and quality control of [(68)Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging
por: Daniel, Thomas, et al.
Publicado: (2023)

Preclinical Assessment Addressing Intravenous Administration of a [(68)Ga]Ga-PSMA-617 Microemulsion: Acute In Vivo Toxicity, Tolerability, PET Imaging, and Biodistribution
por: Mandiwana, Vusani, et al.
Publicado: (2021)

Synthesis, validation and quality controls of [(68)Ga]-DOTA-Pentixafor for PET imaging of chemokine receptor CXCR4 expression
por: Sammartano, Antonino, et al.
Publicado: (2020)

[(68)Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [(18)F]FDG and laboratory values
por: Lapa, Constantin, et al.
Publicado: (2017)

Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients
por: Lewis, Richard, et al.
Publicado: (2021)

Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2
por: Lawal, Ismaheel O., et al.
Publicado: (2022)

Imaging of chemokine receptor CXCR4 expression in culprit and nonculprit coronary atherosclerotic plaque using motion-corrected [(68)Ga]pentixafor PET/CT
por: Derlin, Thorsten, et al.
Publicado: (2018)

CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [(68)Ga]Ga-Pentixafor in CRC Imaging
por: Benčurová, Katarína, et al.
Publicado: (2022)

(68)Ga-Pentixafor PET/CT May Fail to Detect Recurrent Multiple Myeloma with Extramedullary Disease
por: Pan, Qingqing, et al.
Publicado: (2023)

Immune Checkpoints, Inhibitors and Radionuclides in Prostate Cancer: Promising Combinatorial Therapy Approach
por: Kgatle, Mankgopo M., et al.
Publicado: (2021)

(68)Ga‐nitroimidazole PET/CT imaging of hypoxia in tuberculosis: A case series
por: Bresser, Philippa L, et al.
Publicado: (2022)

PSMA Theranostics: Science and Practice
por: Mokoala, Kgomotso, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pbf3v4q9nu3qcuip96cvt9ahvi